breast cancer metastatic

Showing 26 - 43 of 43

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Metastatic Trial in Ravensburg (Ribociclib, Anastrozole, Letrozole)

Active, not recruiting
  • Breast Cancer Metastatic
  • Ravensburg, Germany
    Studienzentrum Onkologie Ravensburg
Mar 7, 2022

Breast Cancer Metastatic, Hormone Receptor Positive Malignant Tumor of Breast Trial in Spain (Combination, Rogaratinib +

Recruiting
  • Breast Cancer Metastatic
  • Hormone Receptor Positive Malignant Neoplasm of Breast
  • Combination, Rogaratinib + palbociclib + fulvestrant
  • Hospitalet de Llobregat, Barcelona, Spain
  • +7 more
Feb 8, 2022

Breast Cancer Metastatic Trial in Beijing, Tai Zhou (standard of care, radiotherapy + standard of care)

Recruiting
  • Breast Cancer Metastatic
  • standard of care
  • radiotherapy + standard of care
  • Beijing, Beijing, China
  • +1 more
Jan 6, 2022

Breast Cancer Stage IV, Triple Negative Breast Cancer, Breast Tumors Trial in Houston (Sitravatinib)

Recruiting
  • Breast Cancer Stage IV
  • +3 more
  • Houston, Texas
    Baylor College of Medicine
Jun 1, 2021

Chemo-induced Peripheral Neuropathy, Breast Cancer Metastatic, Platinum-resistant Recurrent Ovarian Cancer Trial in Iowa City,

Recruiting
  • Chemotherapy-induced Peripheral Neuropathy
  • +2 more
  • Nicotinamide Riboside
  • Iowa City, Iowa
  • +1 more
Apr 26, 2021

Breast Cancer Metastatic Trial in Italy (Everolimus, Aromatase Inhibitors)

Completed
  • Breast Cancer Metastatic
  • Ancona, AN, Italy
  • +15 more
Dec 2, 2020

HER2-positive Breast Cancer, Breast Cancer Metastatic Trial in Kansas City, Overland Park, Lee's Summit (Palbociclib 75mg,

Active, not recruiting
  • HER2-positive Breast Cancer
  • Breast Cancer Metastatic
  • Palbociclib 75mg
  • +5 more
  • Kansas City, Kansas
  • +4 more
Nov 23, 2020

Breast Cancer Metastatic, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation Trial in Shanghai (SC10914)

Unknown status
  • Breast Cancer Metastatic
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 18, 2020

Breast Cancer Metastatic Trial in Seoul

Unknown status
  • Breast Cancer Metastatic
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Apr 28, 2020

    E-Health Portal for Individualized Treatment Monitoring and

    Unknown status
    • Breast Cancer Metastatic
    • patient-reported-outcomes
    • Tübingen, Germany
      Department for Women's Health
    Feb 10, 2020

    Breast Cancer Metastatic Trial in Taipei (Margetuximab, Trastuzumab, Chosen Chemotherapy (Capecitabine))

    Unknown status
    • Breast Cancer Metastatic
    • Taipei, Taiwan
      National Taiwan University Hospital
    Feb 6, 2020

    Cancer Cell Extravasation Through mRNA Analysis of

    Completed
    • Breast Cancer Metastatic
    • Tissue samples collection and cells isolation
    • Milan, Italy
      IRCCS Galeazzi Orthopedic Hospital
    Aug 5, 2019

    Breast Cancer Metastatic Trial in Worldwide (PF-03084014, Docetaxel)

    Terminated
    • Breast Cancer Metastatic
    • Birmingham, Alabama
    • +15 more
    Mar 14, 2019

    Brain Metastases, Lung Cancer Metastatic, Breast Cancer Metastatic Trial in Jacksonville (DCVax-Direct)

    Unknown status
    • Brain Metastases
    • +2 more
    • DCVax-Direct
    • Jacksonville, Florida
      Mayo Clinic
    Aug 17, 2018

    Breast Cancer Metastatic Trial in India (Fixed-dose combination of capecitabine and cyclophosphamide SAR439281)

    Completed
    • Breast Cancer Metastatic
    • Fixed-dose combination of capecitabine and cyclophosphamide SAR439281
    • Kollkata, India
    • +4 more
    Jan 30, 2018

    Breast Cancer Metastatic Trial in ShiJiazhuang (Apatinib)

    Unknown status
    • Breast Cancer Metastatic
    • ShiJiazhuang, Hebei, China
      Fourth Hospital of Hebei Medical University
    Jan 14, 2018

    Breast Cancer Metastatic, Brain Metastases Trial in Beijing (whole brain radiotherapy)

    Unknown status
    • Breast Cancer Metastatic
    • Brain Metastases
    • whole brain radiotherapy
    • Beijing, Beijing, China
      Affiliated Hospital of Academy of Military Medical Sciences
    Dec 21, 2016

    Breast Cancer Metastatic Trial in 809 Madu1-dong, Ilsandong-gu, Goyang-si (Irinotecan plus capecitabine)

    Completed
    • Breast Cancer Metastatic
    • Irinotecan plus capecitabine
    • 809 Madu1-dong, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea, Republic of
      National Cancer Center
    Dec 27, 2011